Sebi warns Dabur India over delay in disclosing USFDA warning letter
Dabur India flagged a risk.
· Business Standard Mkts
The market regulator has cautioned Dabur India over delayed disclosure of a USFDA warning letter, saying repeated violations could attract enforcement action under Sebi rules.
The analysis
Against that, the stock is -1.2% on the day at ₹380.35, and has returned -7.5% over three months. It sits 28% below its 52-week high, which means a good deal of bad news was already in the price. The fmcg sector has moved -5.2% over the same period, so Dabur India is running 2.3 points behind its peers.
This is an USFDA action event. US regulatory status gates the export revenue that drives most Indian pharma earnings. A clearance reopens filings from that site; an alert freezes them, and the impact lands over quarters rather than days. On the day the stock is -1.2%, so a modest reaction.
For Dabur India, the question is how much of this is already reflected in the price and how much re-rates the fmcg peer set alongside it.
Why it matters
- With SEBI involved, this carries a regulatory dimension that can outlast the immediate market reaction.
Market context
- In focus: Dabur India (DABUR), in FMCG.
- Over three months: Dabur India -7.5% against FMCG -5.2% (2.3 points behind).
- At least 25% below the 52-week high: Dabur India (28%).
| Company | Price | Day | 1M | 3M | From 52-wk high | Volume vs 20-day | Market cap |
|---|---|---|---|---|---|---|---|
| Dabur IndiaDABUR · FMCG | ₹380.35 | -1.2% | -2.2% | -7.5% | -27.6% | 1.2× | — |
FMCG
1M -0.2% · 3M -5.2%
Dabur India
Prices as of 6 Nov 2026, 16:11 IST. Sector moves are the average of the stocks we track in each sector.
In this story
Related coverage
Who is Herjit Singh Bhalla? Dabur India appoints CEO as Whole-time Director for a five-year term from November 14
Dabur elevates Herjit Bhalla to board as Mohit Malhotra steps down as CEO
Chandra hire D’Souza is Voltas chair; Trent MD joins board
Marico to acquire 51% stake in Bonorizon Consumer Ventures for ₹35 crore
Honasa Consumer Q2 Results: Mamaearth Parent Posts PAT Growth Of 87% YoY To Rs 73 Crore, Margin Improves